Related references
Note: Only part of the references are listed.Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia
Jacobo Sellares et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD
Ernesto Crisafulli et al.
CHEST (2013)
Cardiac Complications in Patients With Community-Acquired Pneumonia Incidence, Timing, Risk Factors, and Association With Short-Term Mortality
Vicente F. Corrales-Medina et al.
CIRCULATION (2012)
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
A. Liapikou et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The natural history of community-acquired pneumonia in COPD patients: A population database analysis
Hana Muellerova et al.
RESPIRATORY MEDICINE (2012)
Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
Dennis Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
R. Malo de Molina et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
The Influence of COPD on Mortality and Severity Scoring in Community-Acquired Pneumonia
Dominic Snijders et al.
RESPIRATION (2010)
Aetiology of, and risk factors for, recurrent community-acquired pneumonia
C. Garcia-Vidal et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected
E. Calbo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C. Crim et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease
L. Molinos et al.
JOURNAL OF INFECTION (2009)
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia
Julio Ramirez et al.
CLINICAL INFECTIOUS DISEASES (2008)
Early mortality in patients with community-acquired pneumonia:: causes and risk factors
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Effects of systemic steroids in patients with severe community-acquired pneumonia
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia
Jennie Johnstone et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Ricard Pifarre et al.
RESPIRATORY MEDICINE (2007)
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
A. Sonia Buist et al.
LANCET (2007)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
COPD is associated with increased mortality in patients with community-acquired pneumonia
M. I. Restrepo et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia
A. Mykietiuk et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
J. Rello et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia
DN Fisman et al.
CLINICAL INFECTIOUS DISEASES (2006)
Chronic obstructive pulmonary disease: current burden and future projections
AD Lopez et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Epidemiology and costs of chronic obstructive pulmonary disease
KR Chapman et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study):: a prevalence study
AMB Menezes et al.
LANCET (2005)
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001
F Holguin et al.
CHEST (2005)
Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century:: a prospective study on the Mediterranean coast of Spain
F Gutiérrez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
JC Hogg
LANCET (2004)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Effectiveness of pneumococcal polysaccharide vaccine in older adults
LA Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
